Broad Institute;Novartis AG;Dana-Farber Cancer Institute, Inc.
发明人:
申请号：
EP17198700.1
公开号：
EP3309263B1
申请日:
2013.06.26
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The invention provides methods of monitoring differential gene expression of biomarkers to determine patient sensitivity to Cyclin Dependent kinase inhibitors (CDKi), methods of determining the sensitivity of a cell to a CDKi, methods of treating a patient with a CDKi and methods of screening for candidate CDKi.
